Delhi/NCR:

Mohali:

Dehradun:

Bathinda:

Mumbai:

Nagpur:

Lucknow:

BRAIN ATTACK:

Investors

General Meetings/ Postal Ballot

Annual General Meeting

Annual Return
Minutes of 23rd Annual General Meeting
Transcript of 23rd Annual General Meeting
Summary of Proceedings of 23rd Annual General Meeting
Voting Results and Scrutinizer’s Report for 23rd Annual General Meeting
Notice under Section 160 of the Companies Act, 2013
Newspaper Publication - Notice of 23rd Annual General Meeting and E-Voting Information
Business Responsibility and Sustainability Report
Disclosure pursuant to SEBI (SBEB & SE) Regulations, 2021
Newspaper Publication - Information regarding 23rd AGM, Dividend and Record Date
Minutes of Annual General Meeting
Max Healthcare – Transcript of 22nd AGM
Voting Results and Scrutinizer’s Report – 22nd AGM
Proceeding of AGM-September 27, 2023
Newspaper Publication – Notice of 22nd Annual General Meeting and E-voting information
Newspaper Publication - Information regarding 22nd Annual General Meeting and Record Date
2022-23
Disclosure pursuant to SEBI (SBEB & SE) Regulations, 2021
Business Responsibility and Sustainability Report 2022-23
2022-23
Newspaper Advertisement for Notice of 19th AGM
Max Healthcare - 21st AGM Script
Voting results and Scrutinizer Report - 21 AGM
Proceeding of AGM-September 26, 2022
Newspaper Advertisement –Notice of 21st AGM
Newspaper Advertisement – Intimation of 21st AGM/ Email Registration
2021-22
2021-22
Max Healthcare - 20th AGM Script
Voting Result & Scrutnizer's Report- 20th AGM
Proceeding of AGM-September 29, 2021
Newspaper Advertisement - Notice of 20th AGM
Newspaper Advertisement – Intimation of 20th AGM/ Email Registration
2020-21
2020-21
MHIL Intimation for Change in Date of 20th AGM
Voting result & Scrutinizer’s Report- AGM
Proceeding of AGM-September 29, 2020
Intimation regarding AGM timings
Newspaper Advertisement for Email Registration
Extract Anual Return
2019-20
2018-19
2018-19
2017-18
2017-18
2015-16
2015-16
2014-15

Resolution Summary

2024-25
  • 2024-25
  • 2023-24
  • 2022-23
  • 2021-22
  • 2020-21

No. of shares outstanding: 971,925,962
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
Adoption of Audited Standalone Financial Statements for the financial year 2023-24 Ordinary Passed 90.109%
99.939% 0.061%
Adoption of Audited Consolidated Financial Statements for the financial year 2023-24 Ordinary Passed 90.109%
99.939% 0.061%
Declaration of final Dividend of ₹1.5 (i.e. 15%) per equity share of face value of ₹ 10 each Ordinary Passed 90.189%
99.481% 0.519%
Appointment of director in place of Mr. Narayan K. Seshadri, who retires by rotation and being eligible offers himself for re-appointment Ordinary Passed 90.185%
94.732% 5.268%
Appointment of Dr. Pranav C. Mehta as an Independent Director of the Company Special Passed 90.022%
99.675% 0.325%
Ratification of remuneration payable to Cost Auditors for the financial year 2024-25 Ordinary Passed 90.133%
100% 0%

No. of shares outstanding: 971,417,233
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
Re-appointment of Mr. Michael Thomas Neeb as an Independent Director of the Company Special Passed 89.000%
99.000% 1.000%
Re-appointment of Mr. Mahendra Gumanmalji Lodha as an Independent Director of the Company Special Passed 89.000%
85.000% 15.000%

No. of shares outstanding 971,580,320
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
Adoption of Audited Standalone Financial Statements for the financial year ended March 31, 2023 together with the reports of board of directors and auditor’s thereon Ordinary Passed 89.933%
100.000% 0.000%
Adoption of Audited Consolidated Financial Statements for the financial year ended March 31, 2023 together with the report of the auditor’s thereon Ordinary Passed 89.933%
100.000% 0.000%
Declaration of final Dividend of ₹ 1 (i.e. 10%) per equity share of face value of ₹ 10 each Ordinary Passed 89.965%
99.54% 0.456%
Appointment of Director in place of Mr. Anil Kumar Bhatnagar, who retires by rotation and being eligible, offers himself for re-appointment Ordinary Passed 89.936%
85.524% 14.476%
Fixation of tenure of Mr. Anil Kumar Bhatnagar, Non-Executive Director for 3 (three) years Ordinary Passed 89.965%
97.011% 2.989%
Appointment of Ms. Amrita Gangotra as an Independent Director of the Company for a term of 5 (five) consecutive years Special Passed 89.936%
99.500% 0.500%
Payment of remuneration to Ms. Amrita Gangotra as an Independent Director of the Company Ordinary Passed 89.965%
99.178% 0.822%
Increase in remuneration of Non-Executive Directors (including Independent Directors) Ordinary Passed 89.965%
99.176% 0.824%
One-time Performance Bonus to Mr. Abhay Soi, Chairman and Managing Director Special Passed 88.987%
76.425% 23.575%
Approval for alteration in Articles of Association of the Company Special Passed 89.965%
96.925% 3.075%
Ratification of remuneration payable to Cost Auditors for the financial year 2023-24 Ordinary Passed 89.965%
100.000% 0.000%

No. of shares outstanding: 971,417,233
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
Appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director Ordinary Passed 89.081%
77.261% 22.739%
Payment of remuneration to Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director Ordinary Passed 89.081%
81.347% 18.653%

No. of shares outstanding: 969,677,260
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
To receive, consider and adopt (a) the audited standalone financial statements of the Company for the financial year ended March 31, 2022 together with the reports of Board of Directors and Auditor’s thereon; and (b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2022 together with the report of the Auditor’s thereon. Ordinary Passed 88.452%
99.999% 0.001%
To note that Mr. Prashant Kumar (DIN-08342577), Non-Executive Non Independent Director, liable to retire by rotation, does not seek re-election as a Director of the Company. Ordinary Passed 88.442%
99.999% 0.001%
Appointment of Mr. Anil Bhatnagar (DIN-09716726) as Non-Executive Non Independent Director in place of Mr. Prashant Kumar (DIN-08342577), liable to retire by rotation. Ordinary Passed 88.463%
98.835% 1.165%
Payment of Remuneration to Mr. Anil Bhatnagar (DIN-09716726) on appointment as Non-Executive Non-Independent Director of the Company Special Passed 88.421%
89.933% 10.067%
Ratification of remuneration of Cost Auditor for the financial year 2022-23. Ordinary Passed 88.462%
100.000% 0.000%
Re-appointment of Mr. Abhay Soi (DIN-00203597) as Chairman and Managing Director of the Company Ordinary Passed 88.268%
94.88% 5.12%
Payment of remuneration to Mr. Abhay Soi (DIN-00203597) on re- appointment as Chairman and Managing Director of the Company. Special Passed 88.421%
85.638% 14.362%
Appointment of Mr. Pranav Amin (DIN-00245099) as Non-Executive Independent Director of the Company. Special Passed 88.421%
99.556% 0.444%
Payment of remuneration to Mr. Pranav Amin (DIN-00245099) on appointment as Non-Executive Independent Director of the Company. Special Passed 88.463%
99.45% 0.55%
Approval of ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2022’ and grant of employee stock options to the eligible employees of the Company. Special Passed 87.327%
80.722% 19.278%
Grant of employee stock options under the ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2022’ to the employees of the Holding Company, if any, and/or Subsidiary Company (ies) of the Company. Special Passed 87.327%
80.722% 19.278%
Revise the limit to make loan(s) or give guarantee(s) or provide security (ies) or make investment(s) in excess of the prescribed limit under Section 186 of the Companies Act, 2013 read with the rules made thereunder. Special Passed 88.421%
84.881% 15.119%
Revise borrowing limit under Section 180(1)(c) of the Companies Act, 2013. Special Passed 88.421%
85.298% 14.702%
Revise limit under Section 180(1)(a) of the Companies Act, 2013, for creation of charge on the assets of the Company, both present and future, in respect of its borrowings. Special Passed 88.421%
84.534% 15.466%

No. of shares outstanding: 969,613,455
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
Appointment of Mr. Prashant Kumar (DIN-08342577) as Non-Executive Non Independent Director of the Company Ordinary Passed 89.284%
95.507% 4.493%
Appointment of Mr. Gaurav Trehan (DIN - 03467781) as Non-Executive Non Independent Director of the Company Ordinary Passed 89.284%
94.397% 5.603%

No. of shares outstanding: 965,945,006
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
Approval of public shareholders of the Company for amending certain provisions of the Shareholders’ Agreement dated December 24, 2018 executed amongst Mr. Abhay Soi (as Promoter) and Kayak Investments Holding Pte. Ltd. (“Kayak”/”Investor”) and in respect of which the Deed of Accession and Adherence was executed by the Company on June 1, 2020 (“Post Merger SHA”), in particular those relating to the Upside Share and Early Exit Upside Share from the Investor to the Promoter pursuant to Regulation 2 Ordinary Passed 28.338%
96.317% 3.683%
Approval for amendments to Articles of Association of the Company pursuant to the Second Letter Amendment Agreement dated September 28, 2021 to Post Merger SHA Ordinary Passed 89.239%
98.83% 1.17%

No. of shares outstanding: 965,945,006
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
To receive, consider and adopt: a. the audited standalone financial statements of the Company for the financial year ended March 31, 2021 together with Reports of the Board of Directors and Auditors thereon; and b. the audited consolidated financial statements of the Company for the financial year ended March 31, 2021 together with the report of the Auditors thereon. Ordinary Passed 89.744%
100.000% 0.000%
To appoint a Director in place of Ms. Ananya Tripathi (DIN: 08102039) who retires by rotation and being eligible, offers herself for re-appointment Ordinary Passed 89.303%
96.614% 3.386%
Ratification of remuneration of Cost Auditors for the financial year 2021-22. Ordinary Passed 89.772%
100.000% 0.000%
Appointment of Ms. Harmeen Mehta (DIN: 02274379) as an Independent Director of the Company. Ordinary Passed 89.303%
99.98% 0.02%
Remuneration to Independent Directors. Special Passed 89.303%
99.515% 0.485%

No. of shares outstanding: 965,945,006
Particulars Types of resolution Outcome Votes polled as % of
shares outstanding
Votes Polled
%Favor %Against
To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2020, together with the Reports of the Board of Directors and Auditors thereon and the audited consolidated financial statements of the Company for the financial year ended March 31, 2020 together with the report of the Auditors thereon. Ordinary Passed 87.027%
100.000% 0.000%
To appoint a Director in place of Mr. Sanjay Omprakash Nayar (DIN-00002615) who retires by rotation and being eligible, offers himself for re-appointment. Ordinary Passed 86.637%
99.751% 0.249%
To appoint M/s Deloitte Haskins & Sells, Chartered Accountants as the Statutory Auditors of the Company, from the conclusion of this Annual General Meeting till the conclusion of 24th Annual General Meeting. Ordinary Passed 87.039%
100.000% 0.000%
To Ratify remuneration payable to M/s Chandra Wadhwa & Co., Cost Accountants for the Financial Year ending March 31, 2021. Ordinary Passed 87.039%
100.000% 0.000%
To approve ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2020’ and grant employee stock options to the eligible employees of the Company. Special Passed 87.039%
95.831% 4.169%
To Grant employee stock options under the ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2020’ to the employees of the Holding Company, if any, and/or Subsidiary Company (ies) of the Company. Special Passed 87.039%
95.831% 4.169%
To issue Securities to Qualified Institutional Buyers. Special Passed 87.039%
100.000% 0.000%
To issue Non-Convertible Debentures (“NCDs”) on Private Placement basis. Special Passed 87.039%
99.977% 0.023%
To increase the Authorized Share Capital of the Company. Ordinary Passed 87.039%
100.000% 0.000%